MaxLinear is trading at $61.67 (-5.53%) amid chip-sector pressure over AI spending concerns and Lam Research supply constraints; available reporting does not establish that its earnings caused the after-hours decline.
- Q3 revenue was $218.1 million and non-GAAP EPS was $0.62, topping analyst estimates; Q4 revenue guidance is $240–$260 million.
- MaxLinear disclosed a credit facility increase to $200 million, with no reported link to the drop. On October 22, the Nasdaq fell 1.26% and the S&P 500 fell 1.15%.